G
Galectin Therapeutics Inc. (GALT)
NCM – Real Time Price. Currency in USD
4.99
+0.76 (17.97%)
At close: Jun 26, 2026, 4:00 PM EDT
4.96
-0.03 (-0.56%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
4.99
+0.76 (17.97%)
At close: Jun 26, 2026, 4:00 PM EDT
4.96
-0.03 (-0.56%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Total debt $135.7M significantly exceeds cash reserves ($14.1M), raising financial stability concerns
Total current assets $15.7M exceed Total current liabilities $7.3M, highlighting excellent liquidity
Debt-to-equity ratio (-1.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-2.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.15 | 6.05 | 10 | |
| Quick ratio | 2.15 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 8.61 | 1.04 | 1.0 | |
| Interest coverage | -2.05 | -16.91 | 1.0 | |
| Weighted average score | 4.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -32K | -33K | -37K | -53K | -55K |
| Operating Income | -38M | -38M | -42M | -20M | -16M |
| Net Income | -39M | -41M | -47M | -31M | -26M |
| EBITDA | -38M | -38M | -42M | -20M | -16M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 25 | 5.5 |
| Next quarter | N/A | 23.08 | 5.5 |
| Current year | N/A | 22.92 | 5.5 |
| Next year | N/A | 10.81 | 4.0 |
| Weighted average score | 5.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 8.25 | 0 | 36.01 | 6.8 |
| Y/Y | 999 | 47.61 | 46.67 | 49.72 | 10 |
| 3y average | 999 | 4.67 | 6.77 | 3.34 | 5.8 |
| 5y average | 999 | -8.61 | -6.29 | -7.13 | 3.3 |
| Weighted average score | 6.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |